February, 2019 | PharmaShots

AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for Neurological Disorders

February 28, 2019June 14, 2019Shiwani Sharma

Shots: AbCellera to receive technology access fee, milestones and royalties on the development and commercialization of pre-cliniocal candidates & will develop Abs for [Read More...]

Novartis and Blackstone Life Sciences Collaborate to Launch Anthos Therapeutics for Cardiovascular Disorders

February 28, 2019June 14, 2019Shiwani Sharma

Shots: Novartis to get minority equity in Anthos and will grant rights to Anthos for MAA868 to develop in CVD. Blackstone Life Sciences [Read More...]

Novartis Signs a Research Agreement with Target PharmaSolutions for Conducting TARGET-DERM Study

February 28, 2019June 14, 2019Shiwani Sharma

Shots: Novartis & Target PharmaSolutions collaborates for the onset of global TARGET-DERM study evaluating adult and pediatric patients with immune-mediated inflammatory skin conditions [Read More...]

Janssen’s Tremfya (guselkumab) Receives FDA’s Approval for Moderate-to-Severe Plaque Psoriasis in Adults

February 28, 2019June 14, 2019Shiwani Sharma

Shots: The approval is based on P-III study results assessing Tremfya (guselkumab, 100mg) vs PBO in 78 patients with moderate-to-severe plaque psoriasis P-III [Read More...]

AstraZeneca’s Farxiga and Xigduo XR Receives FDA’s Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment

February 28, 2019June 14, 2019Shiwani Sharma

Shots: The expanded label approval is based on P-III DERIVE study results assessing Farxiga (dapagliflozin 10 mg) vs PBO in patients with type [Read More...]

Sarepta Exercises its Exclusive Option to Acquire Myngonexus Therapeutics for $165M

February 27, 2019June 14, 2019Shiwani Sharma

Shots: Sarepta exercises its option to acquire Myonexus Therapeutics, in all stock transaction for $165M with its five Limb-girdle muscular dystrophy (LGMDs) gene [Read More...]

Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA’s Approval for Expanded Indication for Chronic Total Occlusion (CTO)

February 27, 2019June 14, 2019Shiwani Sharma

Shots: The expanded indication approval is based on PERSPECTIVE Study assessing 183 patients with older-generation Resolute Integrity DES The study resulted in low [Read More...]

Imbrium Signs a License Agreement with TetraGenetics for its TetraExpress Technology

February 27, 2019June 14, 2019Shiwani Sharma

Shots: TetraGenetics to receive $25M upfront, $248M milestones as contingent payments, FTE payments and royalties upto 7% on sales of product. Imbrium to [Read More...]

Roche and Immatics Collaborate to Evaluate IMA101 + Tecentriq (atezolizumab) for Solid Cancers

February 27, 2019June 14, 2019Shiwani Sharma

Shots: The companies enter into a clinical research collaboration for the evaluation of efficacy and safety of immunotherapy combining Roche’s Tecentriq (atezolizumab) with [Read More...]

AstraZeneca and Merck Report Result of Lynparza (olaparib) in P-III POLO Trial for BRCA-Mutated Metastatic Pancreatic Cancer #ASCO2019

February 27, 2019February 13, 2020Shiwani Sharma

Shots: The P-III POLO study involves assessing of Lynparza (olaparib, 300mg, bid) vs PBO in 154 patients in ratio (3:2) with BRCAm metastatic [Read More...]